Genelux Corporation (GNLX) Stock Forecast
GNLX analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.83 / 5 from 6 analysts
- Price target
- $18.83 average of analyst targets
- Upside to target
- +678.2% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.20
- 52-week range
- $2.30 – $8.24
GNLX analyst ratings
6 analystsNumber of analysts at each rating.
GNLX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
GNLX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.20 | −$0.22 | −$0.18 | −$0.21 | +5.6% | 6 |
| Current fiscal year (2026) | −$0.81 | −$0.86 | −$0.77 | −$0.86 | +5.2% | 6 |
| Next fiscal year (2027) | −$0.75 | −$0.92 | −$0.56 | −$0.81 | +7.8% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
GNLX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 6 |
| Current fiscal year (2026) | $0 | $0 | $0 | −100.0% | 6 |
| Next fiscal year (2027) | $7.8M | $0 | $16.9M | 0.0% | 6 |
GNLX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
GNLX revenue: reported and forecast
GNLX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.20 | −$0.20 | −$0.20 | −$0.19 | −$0.20 | −2.5% | 2 up · 1 down |
| Current fiscal year (2026) | −$0.81 | −$0.81 | −$0.82 | −$0.81 | −$0.81 | 0.0% | 1 up · 3 down |
| Next fiscal year (2027) | −$0.76 | −$0.76 | −$0.75 | −$0.74 | −$0.75 | −1.4% | 2 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
GNLX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; GNLX beat in 6 of 12.
What analysts expect from GNLX
6 analysts cover Genelux; their consensus rating is strong buy (4.83 on a 1–5 scale, where 5 is a strong buy). The average price target is $18.83, 678.2% above the latest close of $2.42. Analysts expect earnings of −$0.81 per share for 2026, +5.2% from a year earlier. For 2027 the average estimate is −$0.75 per share on revenue of $7.8 million. Genelux beat the EPS estimate in 6 of the last 12 quarters.
Related: GNLX income statement, GNLX key metrics, GNLX chart. See the GNLX stock overview for the latest quote and news.
GNLX forecast FAQ
What is Genelux's price target?
The average analyst price target for Genelux is $18.83, 678.2% above the latest close of $2.42.
Is Genelux a buy, hold or sell?
Of 6 analysts covering Genelux, 5 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Genelux's EPS forecast?
Analysts forecast −$0.81 per share for 2026 (range −$0.86 to −$0.77); for 2027 the estimate is −$0.75.
When does Genelux report earnings?
Genelux is expected to report results for the quarter ending September 30, 2026 on November 4, 2026; the EPS estimate is $-0.20.
Does Genelux usually beat earnings estimates?
Genelux reported EPS at or above the analyst estimate in 6 of the last 12 quarters.